Home » Impurities » Sorafenib Tablets

Sorafenib Tablets

Sorafenib Tablets Impurities & Reference Standards

Sorafenib Tablets is recognized as an active pharmaceutical ingredient (API) that supports formulation development, process validation, and quality assurance in drug manufacturing. Analytical laboratories rely on Sorafenib Tablets and its associated impurity standards for method development, quality control testing, and pharmacopoeial compliance (ICH, USP, BP, EP). Our Sorafenib Tablets reference standards are provided with full documentation — Certificate of Analysis (CoA), HPLC chromatographic data, and spectral characterization — to support pharmaceutical R&D and GMP manufacturing.


Associated Impurities

Sorafenib Tablets Impurity – A

  • CAS No: 284462-37-9
  • Mol. F.: C13H13N3O2

Sorafenib Tablets Impurity – C

  • CAS No: 320-51-4
  • Mol. F.: C7H5ClF3N

Sorafenib Tablets Impurity – D

  • CAS No: 2206827-14-5
  • Mol. F.: C17H19N3O4

Sorafenib Tablets Impurity – E

  • CAS No: 284670-98-0
  • Mol. F.: C27H24N6O5

Sorafenib Tablets Impurity – F

  • CAS No: 1285533-84-7
  • Mol. F.: C21H17F3N4O3

Sorafenib Tablets Impurity – G

  • CAS No: 18585-06-3
  • Mol. F.: C10H9ClF3NO2

Sorafenib Tablets Impurity – H

  • CAS No: 1431697-81-2
  • Mol. F.: C21H16ClF3N4O3
Scroll to Top